Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

Paeds Casesrheumatology-musculoskeletal-and-sports

Paeds Cases · rheumatology-musculoskeletal-and-sports

Scleroderma, mixed connective-tissue disease and overlap syndromes: Case

Clinical long case of a six-year-old boy presenting with the linear scleroderma of the right lower limb, covering the recognition of the active localised disease, the Zulian classification, the methotrexate first-line therapy with the corticosteroid bridging, the physiotherapy for the contracture, and the contrast with the juvenile systemic sclerosis and the mixed connective-tissue disease across the spectrum.

paediatric rheumatology long case3 min readVerification in progress

Target exams

RACP DCEMRCPCH ClinicalRCPSC Pediatrics
On this page
Study tools

Target exams

RACP DCEMRCPCH ClinicalRCPSC Pediatrics
Prompt
A six-year-old boy is referred by his general practitioner for a band of hard, shiny skin that has grown down the medial aspect of his right thigh and shin over the last five months, crossing the right knee. The mother has noticed that he now walks with a slight limp and cannot fully straighten the knee. He is otherwise well, with no Raynaud phenomenon, no systemic symptoms, and a normal blood pressure. The examiner asks how you frame the problem, how you confirm and classify the disease, how you treat it, and how you contrast the localised scleroderma with the systemic disease and the overlap syndrome.

Framing the case

This six-year-old boy has the classic presentation of the linear scleroderma, the commonest subtype of the juvenile localised scleroderma. The band of hard, shiny skin crossing the right knee, the five-month duration, the violaceous active edge, and the loss of the full extension together declare the active linear disease, and the limp is the functional consequence of the tethered joint. The framework that organises the case is the localised scleroderma, the skin-confined family, and the urgent need to halt the active inflammation before the contracture fixes in the growing child. [6][7]

Immediate assessment and the classification

The assessment begins with the recognition that this is the localised and not the systemic disease. The absence of the Raynaud phenomenon, the sclerodactyly, the nailfold changes and the systemic symptoms places the lesion in the localised family, and the band morphology places it in the linear subtype. The Zulian classification, drawn from the seven hundred and fifty children, sorts the localised disease into the circumscribed morphea, the linear scleroderma, the generalised morphea, the pansclerotic morphea and the mixed morphea, and the linear subtype is the commonest in children, around two-thirds. The band is photographed and mapped, the joint range is measured, and the limb length is compared for the asymmetry. [6][8]

The band crossing a joint in the growing child produces the permanent contracture

The linear band that crosses the knee in this six-year-old tethers the growing bone beneath it, and unless the active inflammation is halted early with the methotrexate, the flexion contracture and the limb-length discrepancy become permanent. The early methotrexate is the single intervention that changes the functional outcome, and the watch-and-wait approach is the error that fails the child.

[9]
Paediatrics Fellowship Pro

Continue reading

You have read the opening of this case. The complete unit — every section and its primary-source references — is part of the Paediatrics Fellowship fellowship library.

Sign in to continueSee pricing
References6ShowHide
  1. [1]Foeldvari I, Pain CE Juvenile systemic sclerosis Best Pract Res Clin Rheumatol, 2026.PMID 41638996
  2. [6]Zulian F, Athreya BH, Laxer R, et al. Juvenile localized scleroderma: clinical and epidemiological features in 750 children. An international study Rheumatology (Oxford), 2006.PMID 16368732
  3. [7]Martini G, Fadanelli G, Agazzi A, Vittadello F, Meneghel A, Zulian F Disease course and long-term outcome of juvenile localized scleroderma: Experience from a single pediatric rheumatology Centre and literature review Autoimmun Rev, 2018.PMID 29729451
  4. [9]Kaushik A, Mahajan R, De D, et al. Paediatric morphoea: a holistic review. Part 2: diagnosis, measures of disease activity, management and natural history Clin Exp Dermatol, 2020.PMID 32449205
  5. [8]Kaushik A, Mahajan R, De D, et al. Paediatric morphoea: a holistic review. Part 1: epidemiology, aetiopathogenesis and clinical classification Clin Exp Dermatol, 2020.PMID 32472964
  6. [10]Chevalier K, Bader-Meunier B, Kone-Paut I, Terrier B, Hachulla E, Mouthon L, Chaigne B, Costedoat-Chalumeau N Juvenile-onset mixed connective tissue disease: A multicenter retrospective cohort study Semin Arthritis Rheum, 2026.PMID 41412094
Paediatrics Fellowship Pro

$29/ monthor $279 / year

The complete Paediatrics Fellowship library, every exam format, one subscription.

  • Complete library for one chosen specialty
  • Timed MCQ mock exams and spaced review
  • Clinical cases & cross-table vivas
See pricingSign in
PreviousReassure and safety-net a transient synovitis diagnosis with a parent — OSCErheumatology-musculoskeletal-and-sportsNextSystemic juvenile idiopathic arthritis and macrophage activation syndrome: Caserheumatology-musculoskeletal-and-sports